Focal therapy with high‐intensity focused ultrasound for prostate cancer: 3‐year outcomes from a prospective trial

To assess the oncological and functional outcomes of focal high-intensity focused ultrasound (HIFU) in treating localised prostate cancer (PCa), a 3-year prospective study was undertaken using periodic post-ablation saturation biopsies.